The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 44 | Highlights from ESSO 44: surgical oncology advances and the role of AI in patient care
Beate Rau, MD, PhD, MBA, FEBS, Charite University Hospital, Berlin, Germany, discusses key highlights from the congress, focusing on advances in surgical oncology including upper and lower GI cancers, rectal cancer, and robotic surgery. She emphasizes the growing role of artificial intelligence (AI) in oncology for interdisciplinary collaboration and clinical decision-making while warning against its commercialization by non-medical stakeholders. Prof. Rau stresses that AI must remain within the medical community to ensure ethical, patient-centered innovation.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
